(LEAD) Celltrion Q2 net profit jumps nearly sixfold on strong biosimilar sales

World 1 source 1 country 🔦 Under-reported 39m ago

SEOUL, July 27 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutica...

Summary from source